← Back to all trials
Withdrawn
NCT03554239
Impact of Genotyping P450 2C19 on Hospitalization Period
Conditions: Infection
Sex: All
Healthy volunteers: No
Phase: NA
Sponsor: University Hospital, Toulouse
Summary
Monocentric study with the objective to evaluate the impact of genotyping CYP2C19 on the hospitalization period. The genotyping will permit to adapt at best the Voriconazole posology.
Eligibility Criteria
Inclusion Criteria:
* Patient with Voriconazole treatment
* Man or woman
* With social security number
Exclusion Criteria:
* Patient or parent of patient who refuse to accept inform consent form
* All patient under protection of adults
Source: ClinicalTrials.gov (NCT03554239). StuddyBuddy aggregates publicly available trial information.
